Please note all speakers and moderators are tentative and subject to change. Final progam will be released prior to the Virtual Symposium. All times are listed in Eastern Time.

November 3-6 | 2021 Virtual Symposium 

December 9, 2021 7pm-9pm EST | NANETS' Annual Membership Meeting: The Future of NETs

Registration for the Annual Membership Meeting will open during the Symposium, you will need to register separately.

Looking for a downladable PDF of the 2021 Schedule? Use the links below

2021 Schedule at a Glance

2021 Full Schedule

 Wednesday  November 3

5:00pm - 6:00pm EDT | Guidelines Working Meetings (Gastric/Duodenal)

6:00pm - 8:00pm EDT | Pre-Conference Workshop- Allied Health 

sheila-lindsay-np.jpg  Moderator: Sheila Lindsay, NP, University of California, San Francisco School of Medicine

Topic: NET Medical Management Overview

FongMeikajpg.jpg Speaker: Mei Ka Fong, PharmD, BCOP, CPP, Carolinas Medical Center and Levine Cancer Institute

Topic: Integrative Management of NETs

nanavatk.jpg Speaker: Kaushal B. Nanavati, MD FAAFP, ABOIM, ABIHM, Upstate University Hospital

Topic: Surgical management of NETs

sextonja.jpg Speaker: Jackie Sexton, BSN, RN, OCN, University of Iowa Hospitals & Clinics

Topic: NET management in community setting

Gosain.jpg Speaker: Rahul Gosain, MD, Guthrie Corning Hospital

Topic: NET management in large center

Ross-Nicole_640x860.jpg Speaker: Nicole Ross, MSN, CRNP, AOCNP, Fox Chase Cancer Center  

Thursday  November 4

4:00pm - 6:00pm EDT | Guidelines Working Meetings (Rectal NETS)

4:00pm - 5:30pm EDT | Virtual "Happy" Hour- Poster Reception

6:00pm - 8:00pm EDT | Pre-Conference Workshop- Early Career 

cchandraskekharan.jpg Moderator: Chandrikha Chandrasekharan, MBBS, University of Iowa Hospitals & Clinics

Topic: Starting up a Lab

Christoper-Heaphy.jpg Speaker: Christopher Heaphy, PhD, Boston University School of Medicine

Topic: Building a program in Health Services Research (HSR)

julie-hallet.png Speaker: Julie Hallet, MD, MSc., FRCSC, Odette Cancer Centre, Sunnybrook Health Sciences Centre

Topic: How to build a program as a Clinical Investigator

jennifer_chan_.jpg Speaker: Jennifer Chan, MD, MPH, Dana-Farber Cancer Institute

Topic: How to Navigate to and through the Mid-Career Phase

chen-herbert.jpg Speaker: Herbert Chen, MD, FACS, University of Alabama at Birmingham

 Friday  November 5

 9:00am - 10:00am EDT | Poster Hall Open

 9:00am - 10:00am EDT | Exhibit Hall Open

10:00am - 10:45am EDT | NET Year in Review


Speaker: Diane Reidy-Lagunes, MD, Sloan Kettering Cancer Center

10:50am - 11:35am EDT | NET Medical Session 1: NET Practice in the midst of the COVID Era

thor-halfdanarson.jpg Moderator: Thorvardur R. Halfdanarson, MD, Mayo Clinic

Topic: Bridges to Therapy

gangia.JPG Speaker: Alexandra Gangi, MD, Cedars-Sinai Samuel Oschin Cancer Center

Topic: Radiology interpretation

David_Dixon_Childs.jpg Speaker: David Childs, MD, Wake Forest Baptist Health

Topic: Lessons Learned: Managing NET patients in Covid era using Virtual care/ non-traditional ways of adapting practice

reddy-sushanth-1588815823.jpg Speaker: Sushanth Reddy, MD, University of Alabama at Birmingham

11:40am - 12:40pm EDT | Young Investigators Oral Presentations

Featuring six top rated Young Investigator Abstracts

christos-fountzilas.jpg Moderator: Christos Fountzilas, MD, Roswell Park Comprehensive Cancer Center

Topic: Comparison of Drug Sensitivity Profiles of Various NEN Spheroids

Tran_Catherine.jpg Oral Presenter: Catherine G Tran, MD, University of Iowa Carver College of Medicine

Topic: Sex-specific transcriptional differences and loss of gene imprinting in pancreatic neuroendocrine tumors

headshot_ivanov_abstracts.jpg Oral Presenter: Nikolay A. Ivanov, BS, Weill Cornell Medicine

Topic: The MAP kinase-activated protein kinase 2 promotes the development and progression of pancreatic neuroendocrine tumors involving action mediated by macrophages

damian-jacenik.jpg Oral Presenter: Damian Jacenik, PhD, University of Utah and University of Lodz

Topic: Race predicts whether surgery is offered in small bowel but not pancreatic neuroendocrine tumors.

Rodrguez-Jorge.jpg Oral Presenter: Jorge Zarate Rodriguez, MD, Washington University in St Louis School of Medicine

Topic: 177Lu dotatate peptide receptor radionuclide therapy in chronic kidney disease patients: a single center experience

sandhya-manohar-16200233.webp Oral Presenter: Sandhya Manohar, MBBS , Mayo Clinic

Topic: Hpg80(circulating progastrin), a novel blood-based biomarker for detection of poorly differentiated neuroendocrine carcinoma and well differentiated neuroendocrine tumors

chauhan_aman.jpg Oral Presenter: Aman Chauhan, MD, University of Kentucky

12:40pm - 1:30pm EDT | NANETS4theWIN Panel Discussion | Exhibit Hall Break

1:30pm - 2:15pm EDT | NET Medical Session 2: Role of Radioembolization in NET liver metastases (SIO Collaboration)

White_Sarah.jpg Moderator: Sarah White, MD, MS, FSIR, Medical College of Wisconsin; Cancer Center -Froedtert Hospital

Topic: Sequencing and combination of LDT with systemic therapies

gaby-gabriel.jpg Speaker: Gaby Gabriel, MD, University of Kentucky

Topic: Ho-166 Radioembolization for mNET (European experience)

49b06b6c-2083-4714-9d45-41786ded8641_Lam.jpg Speaker: Marnix Lam, MD, PhD, University Medical Center Utrecht, Netherlands

Topic: Pros for Y-90 Radioembolization for mNET

Siddharth-Padia.jpg Speaker: Siddharth Padia, MD, UCLA Medical Center

Topic: Cons for Y-90 Radioembolization for mNET

Brown_photo_1_-_Karen_Brown.jpg Speaker: Karen Brown, MD, University of Utah Health Hospitals and Clinics

2:20pm - 3:20pm EDT | NET Tumor Board

Sri_Tella.jpg Case Presenter: Sri Harsha Tella MD, FACP, Mayo Clinic

NamrataVijayvergia640x860.jpg Case Presenter: Namrata (Neena) Vijayvergia, MD, Fox Chase Cancer Center

Das_Satya_0.jpg Panelist: Satya (Nanu) Das, MD, MSCI, Vanderbilt University

Huma_Rana.jpg Panelist: Huma Q. Rana, MD, MPH, Dana-Farber Cancer Institute

RS15891_Ronadip_Banerjee-rt_copy.jpg Panelist: Ronadip Ralph Banerjee, MD, PhD, The University of Alabama at Birmingham

maluccio-3053e96218.png Panelist: Mary A Maluccio, MD, MPH, FACS, Ochsner Health

Goodman.jpg Panelist: Karyn A Goodman, MD, MS, Mount Sinai

3:20pm - 4:05pm EDT | NET Medical Session 3: Treatment of metastatic Pheochromocytoma/Paraganglioma

Session will highlight the recent Guidelines and review 1-2 clinical cases

kimberly_perez.jpg Moderator: Kimberly Perez, MD, Dana-Farber Cancer Institute

Fishbein_2016_headshot.jpg Panelist: Lauren Fishbein, MD, PhD, University of Colorado School of Medicine

jaydi_delrivero_-_235px.jpg Panelist: Jaydira Del Rivero, MD, National Cancer Institute

camillo_jimenez.jpg.resize.jpg Panelist: Camilo Jimenez, MD, University of Texas MD Anderson Cancer Center

4:10pm - 4:55pm EDT | Abstracts 1 (Basic/Translational Science)

renata_2019_2.jpg Moderator: Renata Jaskula-Sztul, PhD, University of Alabama

Topic: Succinate accumulation is not sufficient for tumorigenesis in mouse chromaffin cells but dual loss of SDHB and NF1 yields SDHx-like pheochromocytomas

 justine annes Oral Presenter: Justin Annes, PhD, Stanford University

Topic: Rabl6a-myc signaling promotes pancreatic neuroendocrine tumor cell proliferation and survival

Salma.jpg Oral Presenter: Ume Salma Shaik Amjad, PhD, University of Iowa

Topic: Cd36 mediated metabolic reprogramming in cancer stem cells contributes to drug resistance to mTOR inhibition in pancreatic neuroendocrine tumors

Profile photo of Yichen (Hailey) Guo Oral Presenter: Yichen Guo, The University of Alabama at Birmingham

Topic: Sunitinib-loaded chondroitin sulfate hydrogels as a novel drug-delivery mechanism for the treatment of pancreatic neuroendocrine tumors

Keutgen-Xavier_261_1.jpg Oral Presenter: Xavier M Keutgen, MD, FACS,  University of Chicago Medicine

 4:55pm-6:00pm EDT | NETworking with the NET Community | Exhibit Hall Break

Join us for an open forum round table session featuring tables for the following:

General NET Community, NET Experts, WIN, GI, NucMed/ IR, Surgeons, Patient Leaders, Mentor and Mentee Matches

6:00pm - 7:05pm EDT | Featured Workshop- NANETS/SNMMI PRRT Workshop | Part I

daniel_halperin.jpg.resize.jpg Moderator: Daniel Halperin, MD, University of Texas MD Anderson Cancer Center

Topic: Updates on imaging in NETs

Lawhn_Heath_Courtney.jpg Speaker: Courtney Lawhn-Heath, MD, University of California, San Francisco School of Medicine

Topic: Setting up PRRT clinic in nuclear medicine for NETs, and patient flow

Jacene-Heather-MD-150x200.jpg Speaker: Heather Jacene, MD, Dana-Farber Cancer Institute

Topic: PRRT in G3 NEN NETs

Mittra.jpg Speaker: Erik S Mittra, MD, PhD, Oregon Health & Science University

7:10pm - 8:30pm EDT | Featured Workshop- NANETS/SNMMI PRRT Workshop | Part II

dasari.jpg Moderator: Arvind Dasari, MD, University of Texas MD Anderson Cancer Center

Topic: The limitations of PRRT

Konda.jpg Speaker: Bhavana Konda, MD, MPH, Ohio State University Comprehensive Cancer Center

Topic: Imaging and patient specific dosimetry in PRRT

RAD_Dewaraja_YuniNEW.jpg Speaker: Yuni Dewaraja, PhD, University of Michigan

Topic: Utility of quantitative dosimetry for optimizing PRRT

AIravani.jpg Speaker: Amir Iravani, MD, Washington University

Topic: non-lutetium-based PRRT (alphas and Y90)

Yusuf.jpg Yusuf Menda, MD, University of Iowa, Carver College of Medicine

 Saturday  November 6

9:00am - 10:00am EDT | Poster Hall Open

9:00am - 10:00am EDT | Exhibit Hall Open 

10:00am - 10:45am EDT | Keynote Presentation

Pheochromocytoma: a Neuroendocrine Tumor in the era of precision medicine


Keynote Speaker: Karel Pacak, DSc, PhD, MD, Senior Investigator, Section on Medical Neuroendocrinology, NICHD/DIR, National Institutes of Health

Eads_Jennifer.jpg Moderator: Jennifer Eads, MD, University of Pennsylvania

10:50am - 11:45am EDT | NET Medical Session 4: Management of liver metastases in NETs

sksherman.jpg Moderator: Scott K. Sherman, MD, University of Iowa, Carver College of Medicine

Topic: Pros for surgical management of liver metastases

 gagandeep_singh.jpg Speaker: Gagandeep Singh, FACS, MD, City of Hope

Topic: Cons for surgical management of liver metastases

Clarke_photo.jpg  Speaker: Callisia N. Clarke, MD, MS, FACS, FSSO, The Froedtert & the Medical College of Wisconsin

raj_1200x800_3.jpg Panelist: Nitya Raj, MD, Memorial Sloan Kettering Cancer Center

Howe.jpg Panelist: James Howe, MD, University of Iowa Hospitals & Clinics

Nishita_Kothary.jpg Panelist: Nishita Kothary, MD, Stanford Hospital and Clinics; Lucile Packard Children’s Hospital

mcconathy_1.jpg Panelist: Jonathan E McConathy, MD, PhD, The University of Alabama at Birmingham

11:50am - 12:35pm EDT | Research Didactic Session

Quelle.jpg Moderator: Dawn Quelle, PhD, University of Iowa, Carver College of Medicine

Topic: Advances in the genetics of Pheo/Para

Dahia.jpg Speaker: Patricia Dahia, MD, PhD, UT Health San Antonio

Topic: Mouse Modeling of Pancreatic NETs

 justine-annes.pngSpeaker: Justin Annes, MD, PhD, Stanford Medicine

Topic: Advances in understanding of Targeted Alpha Therapy

Schultz.jpg Speaker: Michael K Schultz, PhD, University of Iowa, Carver College of Medicine

12:35pm - 1:20pm EDT | Visit Poster Hall or Booth Exhibit Hall | Break

1:25pm - 2:30pm EDT | Abstracts 2 (Clinical)

Ramirez_Robert.jpg  Moderator: Robert Ramirez, DO, FACP, Vanderbilt University Medical Center

Topic: The safety and efficacy of PEN-221 somatostatin analog (SSA)-DM1 conjugate in patients (PTS) with advanced GI mid-gut neuroendocrine tumor (NET): Phase 2 Results

daniel_halperin.jpg.resize.405.575.high.jpg Oral Presenter: Daniel M. Halperin, MD, The University of Texas MD Anderson Cancer Center

Topic: Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): results from the phase 3 SPINET study

180221-km-msk-lagunes-26r_1200x800_2.jpg Oral Presenter: Diane Reidy-Lagune, MD, Memorial Sloan Kettering Cancer Center

Topic: Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects with Advanced Neuroendocrine Tumors

bassel-el-rayes_scroll2-654x923.jpeg Oral Presenter: Bassel F El-Rayes, MD, Winship Cancer Institute at Emory University

Topic: A prospective study of carcinoid crisis with no perioperative octreotide

Pommier.jpg Oral Presenter: Rodney F. Pommier, MD, FACS, Oregon Health & Science University

 Topic: A Phase 2 Study of Surufatinib in Combination with Toripalimab in Patients with Advanced Neuroendocrine Carcinoma

Ming_Lu.jpg Oral Presenter: Ming Lu, MD, Peking University Cancer Hospital & Institute

Topic: Phase 2 Trial of Pembrolizumab-based therapy in previously treated extrapulmonary poorly-differentiated neuroendocrine carcinomas: Results of Part B (pembrolizumab plus chemotherapy)

JenChan-214x300.jpg Oral Presenter: Jennifer A Chan, MD, MPH, Dana-Farber Cancer Institute

2:35pm - 3:20pm EDT | The Grantees Perspective on NET Research and the Advancement of NET Medicine

2020 Grant Recipients give their insight into the process, successes and challenges around their grant work

ElHaddadGhassan.jpg Moderator: Ghassan El-Haddad, MD, Moffitt Cancer Center

Heloisa-Soares-MD_2.jpg Panelist: Heloisa Soares, MD, PhD, Huntsman Cancer Center, University of Utah Health

2019-finnerty.jpg Panelist: Brendan Finnerty, MD, Weil Cornell Medicine

Keutgen-Xavier_261.jpg Panelist: Xavier Keutgen, MD, University of Chicago Neuroendocrine Tumor Center

3:20pm - 3:40pm EDT | Visit Poster Hall or Booth Exhibit Hall | Break

3:45pm - 4:30pm EDT | NET Medical Session 5: Special Populations in NETS

RWong_Head_Shot_2015.jpg Moderator: Rebecca Wong, MBChB, FRCPC, MSc, Princess Margaret Cancer Center University of Toronto

Topic: Population Disparities in Neuroendocrine tumors

rose-john-1952625907.jpg Speaker: J. Bart Rose, III, MD, University of Alabama at Birmingham

Topic: Young Adult considerations for treatment and diagnosis

Thomas.jpg Speaker: Stefanie Thomas, MD, MS, Cleveland Clinic

Topic: Engaging with rare subpopulations in clinical trials

glasser.png Speaker: Kathryn Glaser, MA, PhD, Roswell Park Comprehensive Cancer Center

4:35pm - 5:15pm EDT | Future Directions in NETS | Closing Remarks

dr-emily-bergsland-md-108-320x320-2x.jpg Moderator: Emily K. Bergsland, MD, University of California, San Francisco School of Medicine

Topic: Ongoing studies: Impact on NET care over the coming 2-5 years

StrosbergJonathan_3489.jpg Speaker: Jonathan R. Strosberg, MD, Moffitt Cancer Center

Topic: Priorities for the future/ CTPM

dr_kunz-13-Edit2.jpg Pamela L. Kunz, MD, Yale School of Medicine

simron_singh.jpg Simon Singh, MD, MPH, FRCPC, Odette Cancer Center, Sunnybrook Health Sciences Centre